The incidence in women less than 35 years of age is increasing despite an overall decrease in newly diagnosed invasive cervical cancer among all age groups. However the influence of young age on prognosis remains controversial. So 163 patients of
invasive cervical cancer in women aged 35 or less treated from Jan. 1, 1984 to Dec. 31, 1993 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea were studied retrospectively.
We obtained the following results; The 5-year survival rates by clinical stage were 88.7% in stage Ib, 71.5% in stageⅡa, 31.2% in stageⅡb and 0% in stageⅢ or above. The lymph node metastasis rates by stage in RAH group, were 21.3% in stage Ib
and
31.8% in stage Ⅱa, The lymph node metastasis rates by lesion size in RAH group, were 19.2% in 2cm below, 20.7% in 2∼4 cm and 40.0% in 4cm above. The 5-year survival rates in RAH group were 74.9% in lymph node positive group and 89.0% in lymph
node
negative group. The recurrence rages by clinical stage were 0% in stage Ia, 20.6% in stage Ib, 22.2% in stage Ⅱb and 90.9% in stage Ⅲor above.
|